In-Vitro Testing Capabilities
At MedPharm, our in vitro testing capabilities offer industry-leading insights into the performance, safety, and efficacy of topical and transdermal formulations. By utilizing highly controlled, reproducible, and scientifically validated methodologies, we assist our clients in optimizing formulations, demonstrating bioequivalence, and confidently meeting regulatory requirements.
Our in-vitro models are designed to replicate human physiological conditions, enabling robust, predictive, and scalable testing across various delivery routes, including dermal, mucosal, ophthalmic, otic, respiratory, and ungual applications.
Regulatory Excellence – All our testing methods comply with FDA, EMA, and ICH guidelines.
Predictive & Reproducible – Our models produce highly reproducible data that correlate with in vivo performance.
Cutting-Edge Technologies – We use proprietary automated diffusion cells and high-resolution imaging to deliver advanced analytics.
Customized Testing Solutions – Whether you need early-stage screening or late-stage validation, our scientists tailor studies to meet your specific development requirements.
With decades of experience in topical and transdermal drug development, MedPharm is the preferred partner for pharmaceutical companies looking to mitigate risks and accelerate their market entry.
Learn More About our In Vitro Testing Services:
MedPharm specializes in testing for ungual and hard tissue formulations, assessing drug penetration into nails, calloused skin, and keratinized structures to support product efficacy and optimization.
For safety, efficacy, and metabolism assessments, MedPharm utilizes reconstructed human epithelium models. This approach allows for accurate, ethical, and reproducible evaluations of topical and transdermal formulations.
By employing automation and rapid screening techniques, our high-throughput permeation testing accelerates early-stage development, enabling us to quickly identify the most effective formulations.
As a gold-standard technique, IVPT assesses drug penetration through biological membranes, providing critical data for product development and regulatory submissions. Our expertise encompasses studies involving human and animal skin, mucosal tissues, and specialized reconstructed epithelial models.
IVRT provides regulatory-compliant drug release assessments, evaluating formulation performance by measuring drug diffusion over time. It is an essential tool for optimizing formulations and for bioequivalence studies in both generic and innovator drug development.